Amneal Pharmaceuticals, Inc. (AMRX)

Pharmaceutical Preparations

Latest Price

$17.22

TTM P/E

35.88

Normalized P/E

Div Yield

Book Value

0.10

P/B Ratio

166.38

Valuation metrics

EPS: $0.22

Target P/E: 36×

Formula: EPS × P/E

P/E Fair Value

$7.92

54% downside

51.4% held by institutions

Institution	Shares	Value	Ownership %	Change	Filing Date
BlackRock, Inc.	26.56M	$459.0M	8.36%	+2.04M	2026-06-30
TPG GP A, LLC	12.33M	$213.0M	3.88%	--	2026-06-30
VANGUARD PORTFOLIO MANAGEMENT LLC	12.14M	$210.0M	3.82%	+812.8K	2026-06-30
Rubric Capital Management LP	10.17M	$176.0M	3.20%	-868.9K	2026-06-30
VANGUARD CAPITAL MANAGEMENT LLC	7.71M	$133.0M	2.43%	+125.1K	2026-06-30
STATE STREET CORP	7.36M	$127.0M	2.32%	+562.3K	2026-06-30
DIMENSIONAL FUND ADVISORS LP	5.79M	$100.0M	1.82%	+103.7K	2026-06-30
GEODE CAPITAL MANAGEMENT, LLC	5.14M	$88.0M	1.62%	+593.4K	2026-06-30
MORGAN STANLEY	4.11M	$71.0M	1.29%	-527.2K	2026-06-30
NEUBERGER BERMAN GROUP LLC	3.89M	$67.0M	1.22%	+204.9K	2026-06-30